ULTRASTRUCTURAL IMMUNOLABELING - A UNIQUE DIAGNOSTIC-TOOL IN MONOCLONAL LIGHT CHAIN-RELATED RENAL DISEASES

被引:37
作者
HERRERA, GA
SANDERS, PW
REDDY, BV
HASBARGEN, JA
HAMMOND, WS
BROOKE, JD
机构
[1] UNIV ALABAMA,DEPT MED NEPHROL,BIRMINGHAM,AL
[2] VET ADM MED CTR,DEPT PATHOL,DENVER,CO
[3] FITZSIMONS ARMY MED CTR,DEPT PATHOL ANAT,AURORA,CO
关键词
AMYLOID; KIDNEY; LIGHT CHAINS; MYELOMA; ULTRASTRUCTURAL LABELING;
D O I
10.3109/01913129409023211
中图分类号
TH742 [显微镜];
学科分类号
摘要
Ultrastructural labeling can play a key role in the evaluation of morphologic expressions of monoclonal light chain-related renal diseases in cases where light microscopy, electron microscopy, and immunofluorescence data, even when combined, are not definitive in conveying a diagnosis and, in other cases, in clarifying the findings by providing immunomorphologic correlation. The important role of ultrastructural labeling is highlighted by the fact that in some of these cases bone marrow aspirates and biopsy specimens obtained at the time of the evaluation of the renal specimens are often unable to establish unequivocally a diagnosis of plasma cell dyscrasia. This is in part because renal manifestations commonly precede overt diagnostic bone marrow alterations. Overt bone marrow findings and clinical manifestations may be preceded for as long as 16 years by the renal manifestations. Determination or confirmation of monoclonality and detection of early deposition of monotypical light chains before the finding of ultrastructural morphologic correlates (ie, subendothelial, punctate, granular, electron-dense material) represent unique attributes of this technique. The increased sensitivity of ultra structural immunolabeling compared with other available diagnostic techniques and its exquisite immunomorphologic correlative capabilities result in a comprehensive evaluation. Sixteen monoclonal light chain-related renal disease cases with early, unusual, or equivocal immunomorphologic manifestations that may have not been characterized properly if ultrastructural labeling had not been performed are presented. The crucial role played by ultrastructural labeling in evaluating these cases and establishing an accurate diagnosis is illustrated and emphasized.
引用
收藏
页码:401 / 416
页数:16
相关论文
共 38 条
[1]  
Antonovych TT, 1974, LAB INVEST, V30, pA370
[2]  
Bell ET, 1933, AM J PATHOL, V9, P393
[3]  
CLAMP JR, 1967, LANCET, V2, P1354
[4]  
COHEN AH, 1980, LAB INVEST, V42, P248
[5]   MULTIPLE MYELOMA WITH FANCONI SYNDROME - STUDY OF A CASE, WITH ELECTRON MICROSCOPY OF KIDNEY [J].
COSTANZA, DJ ;
SMOLLER, M .
AMERICAN JOURNAL OF MEDICINE, 1963, 34 (01) :125-&
[6]   ACUTE RENAL-FAILURE IN MULTIPLE-MYELOMA [J].
DEFRONZO, RA ;
HUMPHREY, RL ;
WRIGHT, JR ;
COOKE, CR .
MEDICINE, 1975, 54 (03) :209-223
[7]  
Forbus WD, 1935, B JOHNS HOPKINS HOSP, V57, P47
[8]  
GALLO G, 1989, SEMIN HEMATOL, V26, P234
[9]  
HERRERA GA, 1988, LAB INVEST, V58, pA38
[10]   ULTRASTRUCTURAL IMMUNOLABELING IN THE DIAGNOSIS OF LIGHT-CHAIN-RELATED RENAL-DISEASE [J].
HERRERA, GA ;
PAUL, R ;
TURBATHERRERA, EA ;
WORK, J ;
VIALE, G ;
DELLORTO, P ;
LOTT, RL ;
COLOMBI, R ;
OLD, CW ;
LYERLY, RH ;
COGGI, G .
PATHOLOGY AND IMMUNOPATHOLOGY RESEARCH, 1986, 5 (02) :170-187